Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Maggino

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Annals of Surgical Oncology|May 19, 2017
Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery?Isabella Frigerio, Paolo Regi, Alessandro Giardino, et al.
Annals of Surgery|June 21, 2016
Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNMGiovanni Marchegiani, Stefano Andrianello, Giuseppe Malleo, et al.
Surgery|April 7, 2016
Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysisMichael Tachezy, Florian Gebauer, Monika Janot, et al.
Surgery|September 18, 2020
Defining postoperative weight change after pancreatectomy: Factors associated with distinct and dynamic weight trajectoriesMaxwell T Trudeau, Fabio Casciani, Victoria M Gershuni, et al.
Annals of Surgery|April 29, 2021
A Pretreatment Prognostic Score to Stratify Survival in Pancreatic CancerThomas Hank, Ulf Hinz, Thomas Reiner, et al.
Annals of Surgical Oncology|November 7, 2019
Defining the Safety Profile for Performing Pancreatoduodenectomy in the Setting of HyperbilirubinemiaBofeng Chen, Maxwell T Trudeau, Laura Maggino, et al.
Annals of Surgical Oncology|October 13, 2022
CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal AdenocarcinomaLaura Maggino, Giuseppe Malleo, Stefano Crippa, et al.
Annals of Surgical Oncology|April 21, 2020
Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal AdenocarcinomaGiuseppe Malleo, Laura Maggino, Cristina R Ferrone, et al.
Annals of Surgery|November 12, 2020
Reassessment of the Optimal Number of Examined Lymph Nodes in Pancreatoduodenectomy for Pancreatic Ductal AdenocarcinomaGiuseppe Malleo, Laura Maggino, Motaz Qadan, et al.
Journal of Surgical Oncology|July 30, 2016
Solid pseudopapillary tumors of the pancreas: Specific pathological features predict the likelihood of postoperative recurrenceGiovanni Marchegiani, Stefano Andrianello, Marta Massignani, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Annals of Surgical Oncology|May 19, 2017
Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery?Isabella Frigerio, Paolo Regi, Alessandro Giardino, et al.
Annals of Surgery|June 21, 2016
Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNMGiovanni Marchegiani, Stefano Andrianello, Giuseppe Malleo, et al.
Surgery|April 7, 2016
Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysisMichael Tachezy, Florian Gebauer, Monika Janot, et al.
Surgery|September 18, 2020
Defining postoperative weight change after pancreatectomy: Factors associated with distinct and dynamic weight trajectoriesMaxwell T Trudeau, Fabio Casciani, Victoria M Gershuni, et al.
Annals of Surgery|April 29, 2021
A Pretreatment Prognostic Score to Stratify Survival in Pancreatic CancerThomas Hank, Ulf Hinz, Thomas Reiner, et al.
Annals of Surgical Oncology|November 7, 2019
Defining the Safety Profile for Performing Pancreatoduodenectomy in the Setting of HyperbilirubinemiaBofeng Chen, Maxwell T Trudeau, Laura Maggino, et al.
Annals of Surgical Oncology|October 13, 2022
CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal AdenocarcinomaLaura Maggino, Giuseppe Malleo, Stefano Crippa, et al.
Annals of Surgical Oncology|April 21, 2020
Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal AdenocarcinomaGiuseppe Malleo, Laura Maggino, Cristina R Ferrone, et al.
Annals of Surgery|November 12, 2020
Reassessment of the Optimal Number of Examined Lymph Nodes in Pancreatoduodenectomy for Pancreatic Ductal AdenocarcinomaGiuseppe Malleo, Laura Maggino, Motaz Qadan, et al.
Journal of Surgical Oncology|July 30, 2016
Solid pseudopapillary tumors of the pancreas: Specific pathological features predict the likelihood of postoperative recurrenceGiovanni Marchegiani, Stefano Andrianello, Marta Massignani, et al.
Pageof 7